Effect of D-leucine-6-luteinizing hormone-releasing hormone ethylamide in patients with hypogonadotropic hypogonadism with anosmia

A. Guitelman, A. M. Mancini, N. J. Aparicio, L. Tropea, O. Levalle, Andrew V Schally

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Four men with hypogonadotropic hypogonadism and anosmia were tested with acute intravenous injections of luteinizing hormone-releasing hormone (LH-RH) and D-leucine-6-LH-RH-ethylamide (D-Leu-6-LH-RH-EA) with a 1-week interval. Each patient was then treated with this drug for 60 days and tested again after this period with an intravenous injection of D-Leu-6-LH-RH-EA. The administration of LH-RH resulted in a significant increase in the LH level in only patient and in follicle-stimulating hormone (FSH) and testosterone increases in none. The analog D-Leu-6-LH-RH-EA resulted in significant increases in LH levels in two patients, in FSH levels in three, and in testosterone levels in one. Results obtained after treatment were closely similar to those observed before treatment. Clinical improvement in terms of increased libido, erection, pubic hair growth, and testicular size was observed. D-Leu-6-LH-RH-EA could be useful in the treatment of patients with hypogonadotropic hypogonadism, a possibility deserving further studies.

Original languageEnglish
Pages (from-to)308-311
Number of pages4
JournalFertility and Sterility
Volume32
Issue number3
StatePublished - Dec 10 1979
Externally publishedYes

Fingerprint

Kallmann Syndrome
Gonadotropin-Releasing Hormone
Leucine
Follicle Stimulating Hormone
Intravenous Injections
Testosterone
Libido
Hypogonadism
Hair
Therapeutics

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Effect of D-leucine-6-luteinizing hormone-releasing hormone ethylamide in patients with hypogonadotropic hypogonadism with anosmia. / Guitelman, A.; Mancini, A. M.; Aparicio, N. J.; Tropea, L.; Levalle, O.; Schally, Andrew V.

In: Fertility and Sterility, Vol. 32, No. 3, 10.12.1979, p. 308-311.

Research output: Contribution to journalArticle

Guitelman, A. ; Mancini, A. M. ; Aparicio, N. J. ; Tropea, L. ; Levalle, O. ; Schally, Andrew V. / Effect of D-leucine-6-luteinizing hormone-releasing hormone ethylamide in patients with hypogonadotropic hypogonadism with anosmia. In: Fertility and Sterility. 1979 ; Vol. 32, No. 3. pp. 308-311.
@article{e257ee51795243879760bdba76613164,
title = "Effect of D-leucine-6-luteinizing hormone-releasing hormone ethylamide in patients with hypogonadotropic hypogonadism with anosmia",
abstract = "Four men with hypogonadotropic hypogonadism and anosmia were tested with acute intravenous injections of luteinizing hormone-releasing hormone (LH-RH) and D-leucine-6-LH-RH-ethylamide (D-Leu-6-LH-RH-EA) with a 1-week interval. Each patient was then treated with this drug for 60 days and tested again after this period with an intravenous injection of D-Leu-6-LH-RH-EA. The administration of LH-RH resulted in a significant increase in the LH level in only patient and in follicle-stimulating hormone (FSH) and testosterone increases in none. The analog D-Leu-6-LH-RH-EA resulted in significant increases in LH levels in two patients, in FSH levels in three, and in testosterone levels in one. Results obtained after treatment were closely similar to those observed before treatment. Clinical improvement in terms of increased libido, erection, pubic hair growth, and testicular size was observed. D-Leu-6-LH-RH-EA could be useful in the treatment of patients with hypogonadotropic hypogonadism, a possibility deserving further studies.",
author = "A. Guitelman and Mancini, {A. M.} and Aparicio, {N. J.} and L. Tropea and O. Levalle and Schally, {Andrew V}",
year = "1979",
month = "12",
day = "10",
language = "English",
volume = "32",
pages = "308--311",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Effect of D-leucine-6-luteinizing hormone-releasing hormone ethylamide in patients with hypogonadotropic hypogonadism with anosmia

AU - Guitelman, A.

AU - Mancini, A. M.

AU - Aparicio, N. J.

AU - Tropea, L.

AU - Levalle, O.

AU - Schally, Andrew V

PY - 1979/12/10

Y1 - 1979/12/10

N2 - Four men with hypogonadotropic hypogonadism and anosmia were tested with acute intravenous injections of luteinizing hormone-releasing hormone (LH-RH) and D-leucine-6-LH-RH-ethylamide (D-Leu-6-LH-RH-EA) with a 1-week interval. Each patient was then treated with this drug for 60 days and tested again after this period with an intravenous injection of D-Leu-6-LH-RH-EA. The administration of LH-RH resulted in a significant increase in the LH level in only patient and in follicle-stimulating hormone (FSH) and testosterone increases in none. The analog D-Leu-6-LH-RH-EA resulted in significant increases in LH levels in two patients, in FSH levels in three, and in testosterone levels in one. Results obtained after treatment were closely similar to those observed before treatment. Clinical improvement in terms of increased libido, erection, pubic hair growth, and testicular size was observed. D-Leu-6-LH-RH-EA could be useful in the treatment of patients with hypogonadotropic hypogonadism, a possibility deserving further studies.

AB - Four men with hypogonadotropic hypogonadism and anosmia were tested with acute intravenous injections of luteinizing hormone-releasing hormone (LH-RH) and D-leucine-6-LH-RH-ethylamide (D-Leu-6-LH-RH-EA) with a 1-week interval. Each patient was then treated with this drug for 60 days and tested again after this period with an intravenous injection of D-Leu-6-LH-RH-EA. The administration of LH-RH resulted in a significant increase in the LH level in only patient and in follicle-stimulating hormone (FSH) and testosterone increases in none. The analog D-Leu-6-LH-RH-EA resulted in significant increases in LH levels in two patients, in FSH levels in three, and in testosterone levels in one. Results obtained after treatment were closely similar to those observed before treatment. Clinical improvement in terms of increased libido, erection, pubic hair growth, and testicular size was observed. D-Leu-6-LH-RH-EA could be useful in the treatment of patients with hypogonadotropic hypogonadism, a possibility deserving further studies.

UR - http://www.scopus.com/inward/record.url?scp=0018293524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018293524&partnerID=8YFLogxK

M3 - Article

C2 - 385362

AN - SCOPUS:0018293524

VL - 32

SP - 308

EP - 311

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 3

ER -